155 related articles for article (PubMed ID: 33565654)
21. Tuberous Sclerosis Complex with Gingival Enlargement in an Adolescent.
Nath S; Prakash J; Singh NN; Prajapati VK
J Coll Physicians Surg Pak; 2018 Mar; 28(3):S16-S18. PubMed ID: 29482692
[TBL] [Abstract][Full Text] [Related]
22. Histopathological features of fibrous cephalic plaques in tuberous sclerosis complex.
Treichel AM; Pithadia DJ; Lee CR; Oyerinde O; Moss J; Darling TN
Histopathology; 2021 Oct; 79(4):619-628. PubMed ID: 33882161
[TBL] [Abstract][Full Text] [Related]
23. The cutaneous manifestations of tuberous sclerosis complex.
Nguyen QD; DarConte MD; Hebert AA
Am J Med Genet C Semin Med Genet; 2018 Sep; 178(3):321-325. PubMed ID: 30246432
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous Manifestations of Tuberous Sclerosis.
Bakić M; Ratković M; Gledović B; Vujović B; Radunović D; Babić V; Prelević V
Acta Dermatovenerol Croat; 2018 Apr; 26(1):73-74. PubMed ID: 29782307
[TBL] [Abstract][Full Text] [Related]
25. The cutaneous features of tuberous sclerosis: a population study.
Webb DW; Clarke A; Fryer A; Osborne JP
Br J Dermatol; 1996 Jul; 135(1):1-5. PubMed ID: 8776349
[TBL] [Abstract][Full Text] [Related]
26. Expression of proteoglycans and glycosaminoglycans in angiofibroma and fibrous plaque skin lesions from patients with tuberous sclerosis.
Papakonstantinou E; Dionyssopoulos A; Pesintzaki C; Minas A; Karakiulakis G
Arch Dermatol Res; 2003 Aug; 295(4):138-45. PubMed ID: 12844226
[TBL] [Abstract][Full Text] [Related]
27. Acral lesions in tuberous sclerosis complex: insights into pathogenesis.
Aldrich CS; Hong CH; Groves L; Olsen C; Moss J; Darling TN
J Am Acad Dermatol; 2010 Aug; 63(2):244-51. PubMed ID: 20462663
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical and biochemical studies on collagen types in angiofibromas and shagreen patches from patients with tuberous sclerosis.
Konomi H; Arima M; Tanaka H; Nagai Y
Brain Dev; 1982; 4(5):367-74. PubMed ID: 6291423
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic distinctions between mosaic forms of tuberous sclerosis complex.
Treichel AM; Hamieh L; Nathan NR; Tyburczy ME; Wang JA; Oyerinde O; Raiciulescu S; Julien-Williams P; Jones AM; Gopalakrishnan V; Moss J; Kwiatkowski DJ; Darling TN
Genet Med; 2019 Nov; 21(11):2594-2604. PubMed ID: 31114024
[TBL] [Abstract][Full Text] [Related]
30. Fibrofolliculoma in a patient with tuberous sclerosis complex.
Misago N; Narisawa Y
Clin Exp Dermatol; 2009 Dec; 34(8):892-4. PubMed ID: 19196303
[TBL] [Abstract][Full Text] [Related]
31. Loss of expression of tuberin and hamartin in tuberous sclerosis complex-associated but not in sporadic angiofibromas.
Fackler I; DeClue JE; Rust H; Vu PA; Kutzner H; Rütten A; Kaddu S; Sander CA; Volkenandt M; Johnson MW; Vinters HV; Wienecke R
J Cutan Pathol; 2003 Mar; 30(3):174-7. PubMed ID: 12641776
[TBL] [Abstract][Full Text] [Related]
32. Cellular senescence of angiofibroma stroma cells from patients with tuberous sclerosis.
Toyoshima M; Ohno K; Katsumoto T; Maki H; Takeshita K
Brain Dev; 1999 Apr; 21(3):184-91. PubMed ID: 10372905
[TBL] [Abstract][Full Text] [Related]
33. Systemic disease manifestations associated with epilepsy in tuberous sclerosis complex.
Jeong A; Wong M
Epilepsia; 2016 Sep; 57(9):1443-9. PubMed ID: 27417921
[TBL] [Abstract][Full Text] [Related]
34. Facial angiofibromas in a mosaic pattern tuberous sclerosis: A case report.
Alshaiji JM; Spock CR; Connelly EA; Schachner LA
Dermatol Online J; 2012 Jul; 18(7):8. PubMed ID: 22863630
[TBL] [Abstract][Full Text] [Related]
35. The Efficacy of Everolimus for Facial Angiofibromas in Tuberous Sclerosis Complex Patients Treated for Renal Angiomyolipoma/Subependymal Giant Cell Astrocytoma.
Wei CC; Hsiao YP; Gau SY; Wu YT; Wu CT; Wu MH; Tsai JD
Dermatology; 2021; 237(3):444-449. PubMed ID: 33032292
[TBL] [Abstract][Full Text] [Related]
36. Successful Long-Term Multimodality Management of Facial Lesions in Tuberous Sclerosis Complex in an Adult Patient.
Seo JY; Kim A; Baek YS; Jeon J
Ann Dermatol; 2023 Nov; 35(Suppl 2):S243-S246. PubMed ID: 38061713
[TBL] [Abstract][Full Text] [Related]
37. Tuberous sclerosis with oral angiofibroma: case report.
Prabhu S; Mahesh KP
Br J Oral Maxillofac Surg; 2010 Apr; 48(3):205-7. PubMed ID: 19640621
[TBL] [Abstract][Full Text] [Related]
38. A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): a pilot study of nine Japanese patients with TSC of different disease severity.
Wataya-Kaneda M; Tanaka M; Nakamura A; Matsumoto S; Katayama I
Br J Dermatol; 2011 Oct; 165(4):912-6. PubMed ID: 21692771
[TBL] [Abstract][Full Text] [Related]
39. Analysis of current data on the use of topical rapamycin in the treatment of facial angiofibromas in tuberous sclerosis complex.
Balestri R; Neri I; Patrizi A; Angileri L; Ricci L; Magnano M
J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):14-20. PubMed ID: 25174683
[TBL] [Abstract][Full Text] [Related]
40. Significant cases of central cusps, enamel pits, and oral fibromas in tuberous sclerosis complex.
Taga H; Yonenaga K; Eno Y; Yasumitsu T; Hatano T; Matsuo A; Takato T
Odontology; 2021 Jan; 109(1):279-283. PubMed ID: 32720211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
